CollPlant Biotechnologies (CLGN) Non Operating Income (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Non Operating Income of $18000.0 for Q1 2026, up 131.58% on a QoQ basis from -$57000.0 in Q4 2025, and down 90.82% year-over-year from $196000.0 in Q1 2025.
CollPlant Biotechnologies (CLGN) Non Operating Income (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies' Non Operating Income history runs 10 years deep, the most recent figure standing at $18000.0 for Q1 2026.
- Quarterly Non Operating Income fell 90.82% year-over-year to $18000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$184000.0 (down 126.14% YoY) and the FY2025 annual result came in at -$6000.0, down 100.93% from the prior year.
- Non Operating Income was $18000.0 for Q1 2026 at CollPlant Biotechnologies, up from -$57000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $379000.0 in Q4 2023 and bottomed at -$196000.0 in Q1 2023.
- A 5-year average of $88411.8 and a median of $92000.0 in 2022 frame the typical range for Non Operating Income.
- Peak annual rise in Non Operating Income reached 759.38% in 2022, while the deepest fall reached 500.0% in 2022.
- CollPlant Biotechnologies' Non Operating Income stood at $275000.0 in 2022, then jumped by 37.82% to $379000.0 in 2023, then plunged by 74.67% to $96000.0 in 2024, then tumbled by 159.38% to -$57000.0 in 2025, then jumped by 131.58% to $18000.0 in 2026.
- Business Quant data shows CLGN's Non Operating Income at $18000.0 in Q1 2026, -$57000.0 in Q4 2025, and $24000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -8.59 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 18,000.00 |
| Dec 31, 2025 | -57,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Mar 30, 2025 | 196,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 216,000.00 |
| Jun 30, 2024 | 196,000.00 |
| Mar 31, 2024 | 134,000.00 |
| Dec 31, 2023 | 379,000.00 |
| Sep 30, 2023 | 225,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | -196,000.00 |
| Dec 31, 2022 | 275,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | 92,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 25,000.00 |